Novel Complement Factor H mutation, a case report of atypical hemolytic uremic syndrome

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Criminology

• Publication date

  2017-02-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.5430/CRIM.V4N2P13
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Atypical Hemolytic–Uremic Syndrome: A Clinical Review

  2016cited by this paper
• Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015

  2015influential reference
• Atypical aHUS: State of the art.

  2015influential reference
• Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights Identifying Novel Treatment Approaches

  2014cited by this paper
• Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation.

  2013cited by this paper
• [Atypical hemolytic uremic syndrome].

  2013cited by this paper
• Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.

  2013cited by this paper
• Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.

  2013cited by this paper
• STEC-HUS, atypical HUS and TTP are all diseases of complement activation

  2012cited by this paper
• Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab

  2012cited by this paper
• Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.

  2010influential reference
• Complement control protein factor H: the good, the bad, and the inadequate.

  2010influential reference
• Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.

  2009cited by this paper
• Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions.

  2005cited by this paper
• A Short Consensus Repeat-Containing Complement Regulatory Protein of Lamprey That Participates in Cleavage of Lamprey Complement 31

  2004cited by this paper
• A histidine to tyrosine replacement in lysosomal acid lipase causes cholesteryl ester storage disease.

  1994cited by this paper
• Suggestions for "safe" residue substitutions in site-directed mutagenesis.

  1991cited by this paper
• Edinburgh Research Explorer Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions

  year unknowncited by this paper

• Clinical presentation and management of atypical hemolytic uremic syndrome in Latin America: a narrative review of the literature

  2024influential citation
• Deleterious Impact of a Novel CFH Splice Site Variant in Atypical Hemolytic Uremic Syndrome

  2019cites this paper
• Atypical Hemolytic Uremic Syndrome.

  2018cites this paper